Integra LifeSciences says Cincinnati plant flooding will cost millions
Integra LifeSciences (IART) expects millions in lost revenue due to flooding at its Cincinnati plant, lowering its 2026 financial forecasts. The company estimates a $7M revenue cut in Q3 and an additional $15M-$20M impact for the year. Full recovery is expected by Q2 2027. The stock dropped 16% to $13.50 on the news.
How this was made
The 30-second read
Why it matters
The incident forces a revenue shortfall, guidance reduction, and a share price decline, while insurance may cover part of the loss.
Market read
First‑report of a material operational disruption that materially lowers guidance and triggers a sharp stock move.
What to watch
Potential demand surge for Integra's products post‑recovery could support a rebound.
Background
Heavy rains caused flash flooding in Cincinnati, damaging Integra's plant that produces specialty surgical technologies.
Ticker impact
Integra LifeSciences disclosed flood damage at its Cincinnati plant, cutting Q3 revenue by $7M and lowering full-year guidance, causing a 16% stock drop.
likely further downside as investors price in delayed production and reduced cash flow
Guidance cut of $15‑$20M and a 16% price decline indicate material impact; insurance may offset some loss but recovery extends into 2027.
Market effects
Specialty surgical device sector may see short‑term pressure as supply disruptions raise concerns.
Midwest manufacturing outlook slightly weakened by flood risk.
Limited to Integra; no broad market effect.
Counterpoint
Insurance recovery could mitigate earnings hit, making the stock oversold.
Key entities
- CompanyIntegra LifeSciences
Medical device maker reporting flood‑related losses.
- ExecutiveStuart Essig
CEO of Integra LifeSciences providing the statement.
